AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Schrödinger, Inc.
Video analysis: SDGR
All videosNo video analysis for this stock yet. Request one from our team.
News: SDGR
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033PR NewswireAUSTIN, Texas, Sept. 14, 2026AUSTIN, Texas, Sept. 14, 2026 /PRNewswire/ -- USA News
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs
NEW YORK--(BUSINESS WIRE)---- $SDGR #AI--Schrödinger announced the formation of Tectora, a biotech it co-founded with NEA and RA Capital, focused on immunology and inflammation therapies.
Jupiter Topco LLC Acquires Shares of 28,299 Schrodinger, Inc. $SDGR
Jupiter Topco LLC bought a new stake in shares of Schrodinger, Inc. (NASDAQ: SDGR) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 28,299 shares of the company's stock, valued at approximately $460,000. A number of other hedge funds
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The live presentation will take place on Monday, September 14, 2026 at 1:05 p.m. E.T. The live webcast can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming molecular discovery wi.
BlackRock Inc. Buys New Shares in Schrodinger, Inc. $SDGR
BlackRock Inc. purchased a new position in Schrodinger, Inc. (NASDAQ: SDGR) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 10,521,724 shares of the company's stock, valued at approximately $170,978,000. BlackRock Inc. owned about 14.25% of Schrodinger as of
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma
RXRX, SDGR, RLAY and ABSI are using AI-powered platforms to transform drug discovery while advancing proprietary clinical pipelines.
Schrodinger Inc (SDGR) Stock Down 4.8% -- Now Undervalued? GF Score: 73/100
On August 14, 2026, Schrodinger Inc (SDGR) shares fell 4.8% to $17.58, continuing a trend of volatility as the stock has fluctuated between a 52-week high of $2
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 12, 2026, the company granted restricted stock units (RSUs) with respect to 3,315 shares of the
